# Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

> **NCT00666679** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 134 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Comparator: mometasone
- **DRUG:** Comparator: montelukast
- **DRUG:** Comparator: placebo (unspecified)

## Key facts

- **NCT ID:** NCT00666679
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666679, "Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00666679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*